SCHEMBL3081797

SCHEMBL3081797

CN1CCC(Oc2ccc(F)cc2)c2ccc(N3C=CC=CC3)cc2C1

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
FAAH O00519 1/20 0.33
SLC6A2 P23975 5/20 0.33
SLC6A4 P31645 5/20 0.33
SLC6A3 Q01959 5/20 0.33
CYP2D6 P10635 1/20 0.33
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
KMT2A Q03164 1/20 0.32
MCHR1 Q99705 3/20 0.32
SSTR4 P31391 1/20 0.31
HTR2A P28223 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3073945 0.87 SSTR4 (0.34) ESR1ESR2MAPTSLC6A2SLC6A4
SCHEMBL3094904 0.84 MCHR1 (0.38) SLC6A2SLC6A4SLC6A3KMT2AMCHR1
SCHEMBL3083318 0.82 MCHR1 (0.37) ESR2MAPTSLC6A4CYP2D6HTR2C
SCHEMBL3069862 0.77 SLC6A4 (0.39) ESR1ESR2MAPTSMN1; SMN2SLC6A2
SCHEMBL3081696 0.76 MCHR1 (0.40) ESR1ESR2MAPTSMN1; SMN2FAAH
SCHEMBL3079184 0.74 MMP13 (0.44) MAPTFAAHSLC6A2SLC6A4SLC6A3
SCHEMBL3083522 0.72 KMT2A (0.38) MAPTSMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL3083463 0.72 DRD2 (0.48) MAPTSMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL3089358 0.71 SLC9A3 (0.44) SLC6A4HTR2CMCHR1HTR2A
SCHEMBL3090257 0.71 MAP4K1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2146720-A1 ARYLOXY-AND HETEROARYLOXY-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR Technology, Inc. (US) 2010-01-27 EP disclosed
WO-2008141082-A1 ARYLOXY-AND HETEROARYLOXY-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR TECHNOLOGY, INC. (US) 2008-11-20 WO disclosed